Whelan Kimberly

 

Kimberly Whelan, M.D., MSPH

Associate Professor of Pediatrics
Acting Division Director
Director, TLC clinic and Childhood Cancer Survivors Program
Director, Hem/ Onc Fellowship Program


Dr. Whelan is a graduate of the University of South Carolina's School of Medicine. She completed her pediatric residency at Vanderbilt University Medical Center and later her fellowship in pediatric hematology and oncology here at UAB. She is currently the Medical Director of the TLC clinic. The focus of her research is the late effects of cancer therapy.

 
rsz dralvasdm 3359

Elizabeth Alva, M.D.

Assistant Professor







 
Smita Bhatia smaller

Smita Bhatia, M.D., MPH

Professor & Vice Chair of Outcomes for Pediatrics
Director of the School of Medicine Institute for Cancer Outcomes and Survivorship
Associate Director for Outcomes Research of the UAB Comprehensive Cancer Center
Associate Director of the Center for Outcomes and Effectiveness Research and Education
Dr. Bhatia's current focus is to establish a comprehensive program for cancer outcomes and survivorship research at UAB. This program will reduce the burden of cancer and its sequelae across all segments of the population through collaborative interdisciplinary, interventional and educational efforts in Pediatrics and other Departments.  She also serves as the Associate Chair for the Children’s Oncology Group (COG), coordinating survivorship research across 200 pediatric oncology institutions in the U.S.  Dr. Bhatia is an elected member in the American Society for Clinical Investigation.
 
ChristyB-Ssmall

Christy Bemrich-Stolz, M.D.

Assistant Professor
Dr. Bemrich-Stolz is an Instructor in the UAB Division of Pediatric Hematology-Oncology.  She is a graduate of the University the University of Alabama School of Medicine.  She completed pediatric residency training at Children’s of Alabama followed by her fellowship training in pediatric hematology-oncology.  While completing her fellowship, she received her MSPH in Outcomes and Effectiveness research at the UAB School of Public Health.  Dr. Bemrich-Stolz’s clinical practice includes general hematology and oncology though she does have a particular interest in caring for patients with sickle cell anemia.  Her research interests include assessment of quality of life, transition to adult care and cost-effectiveness of treatment for patients with sickle cell disease.

 
Chewning_post

Joseph Chewning, M.D.

Associate Professor of Pediatrics
Blood and Marrow Transplantation Program
Dr. Chewning is a graduate of Davidson College and the University of South Carolina Medical School. After completing a pediatric residency and a chief residency year at Erlanger Hospital in Chattanooga, he trained in pediatric hematology-oncology at Memorial Sloan-Kettering Cancer Center.  Dr. Chewning remained at Memorial Sloan-Kettering where he did an additional fellowship in bone marrow transplantation while performing human Natural Killer Cell research.  Currently, Dr. Chewning's research focus is translational studies for the prevention and treatment of graft versus host disease.  Dr. Chewning is developing novel mouse models exploring the role of CD4+ T cell lineages in mediating graft versus host disease.  Dr. Chewning is also designing clinical research protocols for mechanisms of chronic graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplantation.
 
SCramer

Stuart Cramer, D.O. 

Assistant Professor
Dr. Cramer is a graduate of the University of Florida and attended Nova Southeastern College of Osteopathic Medicine in Ft. Lauderdale Florida for medical school.  After medical school, he went on to complete his pediatric residency at the University of South Carolina and his Pediatric Hematology and Oncology fellowship at UAB.  Dr. Cramer is interested in cancer cell biology, specifically chemotherapeutic drug resistance.  He is currently working in collaboration with Dr. Mary-Ann Bjornsti, chair of the Department of Pharmacology and Toxicology, investigating the experimental drug MLN 8237 an Aurora A kinase inhibitor in neuroblastoma.  As a fellow, Dr. Cramer received research funding from the St. Baldrick’s Foundation allowing him to explore the role drug transporters play in neuroblastoma drug resistance, and has been granted an extra year of funding by the foundation.  Dr. Cramer hopes that a better understanding of cancer cell resistance will improve outcomes in hard to treat pediatric cancers.
 
Friedman

Gregory Friedman, M.D.  

Associate Professor of Pediatrics   
Neuro-Oncology Program
Dr Friedman is a graduate of the College of William and Mary and the Medical College of Georgia.  He completed his pediatric residency and fellowship in pediatric hematology/oncology at UAB, and is board certified in pediatrics and pediatric hematology/oncology.  His primary interests are pediatric neuro-oncology and conducting pediatric brain tumor research. His overarching goal is to improve outcomes for children with malignant brain tumors by developing and improving novel, targeted therapeutics like oncolytic engineered herpes simplex virotherapy (oHSV) in the lab and then translating these therapies to clinical trials to benefit children with brain tumors and other solid tumors. To maximize the benefit of oHSV to treat chemo- and radio-resistant brain tumors, his lab focuses on determining mechanisms of therapeutic resistance to oHSV by exploring the role of tumor genotype, phenotype, the tumor microenvironment, and cellular defense mechanisms so that newer viruses and unique routes of virus delivery may be developed to circumvent resistance mechanisms.
 
Goldman_post

Frederick Goldman, M.D.

Professor of Pediatrics
Director, Lowder Pediatric Blood and Marrow Transplantation Program
Senior Scientist Immunology & Cancer Immunotherapeutics Program
UAB Comprehensive Cancer Center
Dr. Goldman is a Professor of Pediatrics and Director of the Lowder Blood and Marrow Transplant Program and a member of the Division of Pediatric Hematology-Oncology. Dr. Goldman is a graduate of the Louisiana State University School of Medicine. He completed pediatric residency training at Tulane Children's Hospital and fellowship training at Denver Children's Hospital.  He did a post-doctoral fellowship in Immunology at National Jewish Center for Immunology.  He is a recent UAB faculty member, joining the program in June, 2009, after being on faculty at the University of Iowa since 1992, where he was the Director of the Pediatric Bone Marrow Transplant program and the Pediatric Immune Disorders program.   He is board certified in Pediatric Hematology Oncology. Dr. Goldman's basic science research focuses on understanding the role of a specific enzyme complex called telomerase in cancer, bone marrow production, and aging, and how this enzyme is crucial in minimizing toxicities of chemotherapy.  In addition, Dr. Goldman is involved in studies of new gene transfer methods to treat marrow failure syndromes (Dyskeratosis congenita) and disorders of hematopoiesis (sickle cell disease).  His clinical interests center on developing protocols utilizing cord blood transplant as a way to treat a wide array of childhood cancers, including ALL and AML, as well as inherited immune deficiencies and marrow failure disorders.  He is also directing clinical studies to asses the role of immunoglobulin to prevent infections in pediatric oncology patients. Dr. Goldman has been recognized for clinical excellence by selection as one of the "Best Doctors in America" from 2006 to the present.
 

HainesHilary Haines, M.D.

Assistant Professor of Pediatrics 
Division of Hematology and Oncology
hhaines@peds.uab.edu
Education

Dr. Haines obtained her undergraduate degree from Louisiana State University, and is a graduate of Louisiana State University School of Medicine in New Orleans.  She completed her pediatric residency and pediatric hematology/oncology fellowship here at UAB.  Following completion of her hematology/oncology fellowship, she completed an additional fellowship in bone marrow transplantation and immunodeficiency at Cincinnati Children's Hospital.  She is board certified in pediatrics and pediatric hematology/oncology.  Dr. Haines' clinical interests include supportive care and treatment of viral infections in bone marrow transplant patients and bone marrow transplant for non-malignant disease such as immunodeficiency and sickle cell disease.

 

HilliardLee M. Hilliard, M.D.

Professor of Pediatrics
Chair, CHS Blood Utilization Committee
Dr. Hilliard's area of focus is hematology.  Specifically, her interests include clinical care and research in sickle cell disease.  Dr. Hilliard focuses on stroke risk assessment and prevention, health care delivery in rural areas, management of iron overload in chronically transfused patients (including the use of erythrocytapheresis) and the use of hydroxyurea in sickle cell disease.




 
howard

Thomas H. Howard, M.D.

Professor of Pediatrics
Director, Hematology Section
Co-Director UAB Comprehensive Sickle Cell Center
Dr. Howard hails from North Carolina, graduated from the University of North Carolina at Chapel Hill in
Chemistry, and received his MD degree from the Johns Hopkins University School of Medicine (JHUSOM).  After completing pediatric residency at The Johns Hopkins Hospital in Baltimore MD, he pursued a pediatric hematology and oncology fellowship with William Zinkham MD in the JHUSOM, Department of Pediatrics.  He is board certified in pediatrics and pediatric hematology and oncology.  He served on the faculty in the schools of medicine at JHU, The University of Virginia (UVA) and at the University of Alabama Birmingham (UAB) since 1985.  He was a Visiting Professor of Medicine at Harvard University in 1993-1994 .  During his career he has served as a member of NIH Hematology Grant Study Sections, as commissioner on state commissions for sickle cell disease and hemophilia, as director of the UAB pediatric hematology section and of pediatrics hematology and oncology divisions. 
Dr. Howard's primary clinical interest is general hematology with a focus on sickle cell disease (SCD), hemophilia and red and white blood cell defects.  Dr. Howard's research career interests and experience include an NIH funded basic research program focused on assembly and regulation of the molecular motor in neutrophils; his clinical research focuses on neurological abnormalities, health care delivery, and novel therapies for SCD.  Currently he is institutional PI for NHLBI studies (The Baby Hydroxyurea Trial, Co-PI on the JHU/UAB Basic and Translational Research Program, The JHU Priapism Project), NINDS grants (The Silent Infarct Transfusion Trial, Hydroxyurea for Silent Infarcts in Sickle Hemoglobinopathies), and HRSA projects (Sickle Cell Treatment Demonstration Project) and industry sponsored trials of a novel pneumococcal vaccine.  He, in collaboration with Lee Hilliard MD, founded and developed the Children and Youth Sickle Network (The CYSNTM), a network of regional, comprehensive SCD clinics focused on prevention of SCD morbidity and mortality. The network, established in 1994, collaborates with local pediatricians, SCDAA chapters, hospital and clinics, is an unique, nationally recognized care system and has served Alabamians continuously since its inception.
 

KutnyMatthew Kutny, M.D.

Assistant Professor of Pediatrics
Dr. Kutny is a graduate of Brown University and Vanderbilt University School of Medicine. He completed training in pediatrics at Vanderbilt University Children’s Hospital. He then trained in Pediatric Hematology/Oncology and Bone Marrow Transplant through the University of Washington at the Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital. Dr. Kutny’s clinical practice includes both general hematology and oncology and bone marrow transplant. His research interests focus on the treatment of pediatric leukemia. He is working to improve risk stratification and treatment allocation for patients with acute myeloid leukemia and developing new targeted treatments for relapsed and de novo leukemia.

 
Landier Wendy 2

Wendy Landier, PhD, R.N.

Associate Professor
Dr. Landier is a leader with Dr. Bhatia in defining the key issues of the late effects of childhood cancer therapy. Her research focuses on understanding and improving health outcomes in cancer survivors. She is a Pediatric Nurse Practitioner and also holds a PhD in Nursing. She Chairs the Nursing Discipline Committee for the Children’s Oncology Group. She is extensively published with approximately 50 peer-reviewed manuscripts and multiple book chapters. She is well funded as an individual and as an active colleague in Dr. Bhatia’s research program. Dr. Landier holds a dual appointment in the School of Nursing where she serves as an important mentor for nursing students.
 
Lebensburger_post

Jeffrey Lebensburger, D.O.

Associate Professor of Pediatrics
Dr. Lebensburger is a graduate of the University of Pennsylvania for undergraduate training and the Nova Southeastern Medical School. After his pediatric residency at Arnold Palmer Hospital for Children in Orlando, Florida, Dr. Lebensburger completed fellowship training in Pediatric Hematology Oncology at St. Jude Children's Research Hospital. His primary focus involves children with disorders of the blood, especially sickle cell Disease, thalassemia, disorders of iron metabolism, and marrow failure syndromes including aplastic anemia. His research focuses on linking knowledge from basic science to clinical care (translational research) especially in sickle cell disease. A long term goal of the research is gene therapy for blood disorders.

 
to Dr. Purnima Singhs

Purmina Singh, PhD

Assistant Professor
Dr. Singh is a collaborator with Dr. Bhatia's cancer outcomes team and is an integral part of the new SOM Institute for Cancer Outcomes and Survivorship.




 
Avi Madan Swain

Avi Madan-Swain, PhD

Professor of Pediatrics
Director, Hope and Cope Psychosocial Program
Dr. Madan-Swain is a Pediatric Psychologist/ Neuropsychologist and Clinical Associate Professor in the Division of Pediatric Hematology/Oncology and Neurology, University of Alabama at Birmingham.   She received her doctorate in clinical psychology from Georgia State in 1998, as well as a doctorate in Special Education from Purdue University in 1984. She completed internship training at the UAB Department of Neuropsychiatry and post-doctoral fellowships in Pediatric Psychology and Neuropsychology at Children's of Alabama and the UAB Department of Pediatrics.  Dr. Madan-Swain has worked extensively with chronically ill children and their families in both inpatient and outpatient settings. She is actively engaged in research focusing on school reentry for chronically ill youth, as well as individual and familial adaptation and coping, quality of life issues and neurocognitive functioning in survivors of childhood leukemia, brain tumors, and blood and marrow transplants.
 
Reddy_post

Alyssa Reddy, M.D.

Professor of Pediatrics
Director, Neuro-Oncology Program
Dr. Reddy is a Professor of Pediatrics, Neurology, and Surgery at UAB.  Dr. Reddy received her undergraduate degrees from Boston University and medical degree from UAB.  She completed residency training in Pediatrics at UAB, fellowship training in Child Neurology at UAB, and training in Pediatric Neuro-Oncology at Children's National Medical Center in DC.  Dr. Reddy was instrumental in starting the UAB Pediatric Neuro-Oncology Clinic in 1998, which today is one of the largest programs of its kind in the US.  Dr. Reddy's research interests include development and implementation of clinical trials for children with nervous system tumors.  She is currently principal investigator (PI) of the international Children's Oncology Group (COG) Atypical Teratoid Rhabdoid trial and serves on the Infant Brain Tumor and Neurology Subcommittees of COG.  Dr. Reddy is also the UAB Institution principal investigator for COG as well as several multi-center treatment and cognitive effects studies.  She is also a Co-Investigator for the UAB Neurofibromatosis Consortium.  Dr. Reddy's goal is to improve the lives of children with brain and spinal cord tumors through outstanding patient care and research.
 
Ana Xavier

Ana Xavier, M.D.

Assistant Professor
Dr. Xavier is a graduate of the University of Sao Paulo in Brazil. She completed her pediatric residency training at the Medical University of South Carolina and fellowship training at Children’s Hospital of Michigan/Wayne State University. She is board certified in both pediatrics and pediatric hematology/oncology. Dr. Xavier’s clinical interests include pediatric leukemias and lymphomas and late effects of childhood cancer therapy.

 
JAW photo 8 19 2011

Julie Wolfson, M.D.

Assistant Professor
Dr. Wolfson is a graduate of University of Florida College of Medicine. She completed her residency training in Pediatrics at Massachusetts General Hospital and later her fellowship in Pediatric Hematology-Oncology at Children’s Hospital Los Angeles. Her research interests include Health Services Research, Access to Health Care, Disparities, Adolescents and Young Adults with Cancer and Sickle Cell Disease. Her clinical interests include pediatric hematology-oncology (leukemia), sickle cell disease, bone marrow transplantation for sickle cell disease.


Zachary LeBlanc, M.D. 

Instructor